Harvard Bioscience, Inc. (HBIO) financial statements (2022 and earlier)

Company profile

Business Address 84 OCTOBER HILL RD
HOLLISTON, MA 01746
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,8215,5486,2375,8158,3172,806
Cash and cash equivalents7,8215,5486,2375,8158,3172,806
Receivables21,83418,34017,39117,07417,76613,879
Inventory, net of allowances, customer advances and progress billings27,58725,97824,70922,67622,26222,689
Inventory27,58725,97824,70922,67622,26222,689
Other current assets4,3415,8205,2203,6583,3554,146
Total current assets:61,58355,68653,55749,22351,70043,520
Noncurrent Assets
Operating lease, right-of-use asset6,8977,0817,2417,4087,7617,927
Property, plant and equipment3,4153,4533,4293,6993,9604,309
Intangible assets, net (including goodwill)85,07486,92888,93490,10791,74191,962
Goodwill57,68957,98758,42458,21958,59057,647
Intangible assets, net (excluding goodwill)27,38528,94130,51031,88833,15134,315
Other noncurrent assets5,3757248108121,0921,896
Total noncurrent assets:100,76198,186100,414102,026104,554106,094
TOTAL ASSETS:162,344153,872153,971151,249156,254149,614
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,9115,6167,4896,4165,9726,739
Accounts payable4,9115,6167,4896,4165,9725,990
Taxes payable     749
Deferred revenue4,2663,6233,6753,6373,7713,559
Debt3,5152,7502,5002,2502,0003,200
Other liabilities10,7629,6707,8236,6357,4785,953
Other undisclosed current liabilities1,8621,8471,7811,7801,8321,797
Total current liabilities:25,31623,50623,26820,71821,05321,248
Noncurrent Liabilities
Long-term debt and lease obligation51,58349,45647,89248,75953,76748,361
Long-term debt, excluding current maturities45,09542,74040,92141,60046,28640,669
Operating lease, liability6,4886,7166,9717,1597,4817,692
Liabilities, other than long-term debt2,0444,0234,1104,6574,7532,838
Deferred income tax liabilities1,5581,5491,5721,8091,8991,906
Other liabilities4862,4742,5382,8482,854932
Total noncurrent liabilities:53,62753,47952,00253,41658,52051,199
Total liabilities:78,94376,98575,27074,13479,57372,447
Stockholders' equity
Stockholders' equity attributable to parent, including:83,40176,88778,70177,11576,68177,167
Common stock452451451448444438
Additional paid in capital225,650225,074225,583234,781232,357231,142
Accumulated other comprehensive loss(10,027)(15,003)(13,868)(14,391)(13,066)(11,974)
Accumulated deficit(132,674)(133,635)(133,465)(133,055)(132,386)(131,771)
Other undisclosed stockholders' equity attributable to parent   (10,668)(10,668)(10,668)
Total stockholders' equity:83,40176,88778,70177,11576,68177,167
TOTAL LIABILITIES AND EQUITY:162,344153,872153,971151,249156,254149,614

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Revenues33,05529,66329,19726,98930,98424,037
Cost of revenue
(Cost of Goods and Services Sold)
(13,495)(13,355)(12,844)(11,558)(13,276)(10,542)
Gross profit:19,56016,30816,35315,43117,70813,495
Operating expenses(17,861)(15,760)(16,295)(15,670)(14,952)(13,313)
Operating income (loss):1,69954858(239)2,756182
Nonoperating expense(568)(503)(690)(445)(3,304)(1,597)
Other nonoperating expense(189)(130)(313)(34)(334)(392)
Interest and debt expense   (70)(98) 
Other undisclosed income from continuing operations before equity method investments, income taxes   7098 
Income (loss) from continuing operations before income taxes:1,13145(632)(684)(548)(1,415)
Income tax expense (benefit)(170)(215)22215(67)317
Net income (loss) available to common stockholders, diluted:961(170)(410)(669)(615)(1,098)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Net income (loss):961(170)(410)(669)(615)(1,098)
Other comprehensive income (loss)4,976(1,135)523(1,325)(1,092)1,730
Comprehensive income (loss), net of tax, attributable to parent:5,937(1,305)113(1,994)(1,707)632

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: